Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9568 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9429 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9137 |
High Similarity |
NPD1549 |
Phase 2 |
0.9065 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9065 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9058 |
High Similarity |
NPD1510 |
Phase 2 |
0.9044 |
High Similarity |
NPD1240 |
Approved |
0.8993 |
High Similarity |
NPD2796 |
Approved |
0.8913 |
High Similarity |
NPD1607 |
Approved |
0.8912 |
High Similarity |
NPD7411 |
Suspended |
0.8844 |
High Similarity |
NPD4380 |
Phase 2 |
0.8792 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD7075 |
Discontinued |
0.8733 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8725 |
High Similarity |
NPD6801 |
Discontinued |
0.869 |
High Similarity |
NPD1511 |
Approved |
0.8667 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD7819 |
Suspended |
0.8611 |
High Similarity |
NPD3750 |
Approved |
0.8571 |
High Similarity |
NPD1512 |
Approved |
0.8562 |
High Similarity |
NPD6799 |
Approved |
0.8543 |
High Similarity |
NPD2801 |
Approved |
0.8542 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8431 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8414 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8414 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8408 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8392 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8377 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8357 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8312 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8276 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8264 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8261 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8252 |
Intermediate Similarity |
NPD6651 |
Approved |
0.825 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8227 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8217 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8207 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8146 |
Intermediate Similarity |
NPD920 |
Approved |
0.8146 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8138 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8075 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8071 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8063 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8063 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8049 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8038 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8037 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.8013 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7987 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD943 |
Approved |
0.7971 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7959 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7958 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7914 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7905 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7895 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7895 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7891 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7866 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7848 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7829 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.781 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7785 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD919 |
Approved |
0.7748 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7746 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7746 |
Intermediate Similarity |
NPD3267 |
Approved |
0.774 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7708 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7697 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7687 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7687 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD3225 |
Approved |
0.766 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7655 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7654 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7643 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7568 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7566 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7562 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7561 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7543 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7536 |
Intermediate Similarity |
NPD9493 |
Approved |
0.75 |
Intermediate Similarity |
NPD1470 |
Approved |
0.75 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1164 |
Approved |
0.75 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7483 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7483 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7483 |
Intermediate Similarity |
NPD411 |
Approved |
0.7483 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7453 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7445 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7429 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7403 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7321 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD2353 |
Approved |
0.732 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7219 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7215 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7203 |
Intermediate Similarity |
NPD17 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7117 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7093 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7086
|
Intermediate Similarity |
NPD6233 |
Phase 2 |